Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1961 1
1967 1
1970 1
1971 1
1973 1
1976 2
1978 1
1979 1
1980 1
1984 1
1989 12
1990 3
1991 4
1992 9
1993 5
1994 6
1995 3
1996 1
1997 3
1998 2
1999 5
2000 1
2001 2
2002 1
2003 1
2004 1
2005 1
2006 4
2007 6
2008 10
2009 6
2010 11
2011 2
2012 3
2013 4
2014 3
2015 3
2016 5
2017 7
2018 5
2019 3
2020 9
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.
Giffin MJ, Cooke K, Lobenhofer EK, Estrada J, Zhan J, Deegen P, Thomas M, Murawsky CM, Werner J, Liu S, Lee F, Homann O, Friedrich M, Pearson JT, Raum T, Yang Y, Caenepeel S, Stevens J, Beltran PJ, Canon J, Coxon A, Bailis JM, Hughes PE. Giffin MJ, et al. Among authors: coxon a. Clin Cancer Res. 2021 Mar 1;27(5):1526-1537. doi: 10.1158/1078-0432.CCR-20-2845. Epub 2020 Nov 17. Clin Cancer Res. 2021. PMID: 33203642 Free article.
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.
Caenepeel S, Brown SP, Belmontes B, Moody G, Keegan KS, Chui D, Whittington DA, Huang X, Poppe L, Cheng AC, Cardozo M, Houze J, Li Y, Lucas B, Paras NA, Wang X, Taygerly JP, Vimolratana M, Zancanella M, Zhu L, Cajulis E, Osgood T, Sun J, Damon L, Egan RK, Greninger P, McClanaghan JD, Gong J, Moujalled D, Pomilio G, Beltran P, Benes CH, Roberts AW, Huang DC, Wei A, Canon J, Coxon A, Hughes PE. Caenepeel S, et al. Among authors: coxon a. Cancer Discov. 2018 Dec;8(12):1582-1597. doi: 10.1158/2159-8290.CD-18-0387. Epub 2018 Sep 25. Cancer Discov. 2018. PMID: 30254093 Free article.
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release.
Zuch de Zafra CL, Fajardo F, Zhong W, Bernett MJ, Muchhal US, Moore GL, Stevens J, Case R, Pearson JT, Liu S, McElroy PL, Canon J, Desjarlais JR, Coxon A, Balazs M, Nolan-Stevaux O. Zuch de Zafra CL, et al. Among authors: coxon a. Clin Cancer Res. 2019 Jul 1;25(13):3921-3933. doi: 10.1158/1078-0432.CCR-18-2752. Epub 2019 Mar 27. Clin Cancer Res. 2019. PMID: 30918018 Free article.
Prognostic significance of serum inflammatory markers in esophageal cancer.
Powell AGMT, Eley C, Chin C, Coxon AH, Christian A, Lewis WG; South East Wales Oesophagogastric Cancer Collaborative. Powell AGMT, et al. Among authors: coxon ah. Esophagus. 2021 Apr;18(2):267-277. doi: 10.1007/s10388-020-00772-3. Epub 2020 Aug 31. Esophagus. 2021. PMID: 32865623 Free PMC article.
AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys.
Goldstein RL, Goyos A, Li CM, Deegen P, Bogner P, Sternjak A, Thomas O, Klinger M, Wahl J, Friedrich M, Rattel B, Lamas E, Min X, Sudom A, Farshbaf M, Coxon A, Balazs M, Arvedson T. Goldstein RL, et al. Among authors: coxon a. Blood Adv. 2020 Sep 8;4(17):4180-4194. doi: 10.1182/bloodadvances.2020002565. Blood Adv. 2020. PMID: 32886754 Free PMC article.
A risk-based approach to cognitive bias in forensic science.
Camilleri A, Abarno D, Bird C, Coxon A, Mitchell N, Redman K, Sly N, Wills S, Silenieks E, Simpson E, Lindsay H. Camilleri A, et al. Among authors: coxon a. Sci Justice. 2019 Sep;59(5):533-543. doi: 10.1016/j.scijus.2019.04.003. Epub 2019 Apr 30. Sci Justice. 2019. PMID: 31472798
152 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page